Leukocyte adhesion deficiency type 1

Search Trials
A Study to Evaluate the Efficacy and Safety of Maralixibat in Subjects With Progressive Familial Intrahepatic Cholestasis (MARCH-PFIC)
Status:
Recruiting
Last Changed:
Aug 7, 2019
First Changed:
Apr 5, 2019
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Placebo-controlled Study of Maralixibat (SHP625) in Pediatric Subjects With Progressive Familial Intrahepatic Cholestasis (PFIC)
Status:
Withdrawn
Last Changed:
Mar 18, 2019
First Changed:
Nov 27, 2017
Disease(s):
Progressive Familial Intrahepatic Cholestasis (PFIC)
Intervention(s):
MaralixibatPlacebo
A Clinical Trial to Evaluate the Safety and Efficacy of RP-L201 in Subjects With Leukocyte Adhesion Deficiency-I
Status:
Recruiting
Last Changed:
Jan 25, 2019
First Changed:
Jan 23, 2019
Disease(s):
Leukocyte Adhesion Defect - Type I
Intervention(s):
RP-L201
Study of ORL-1F (L-fucose) in Patients With Leukocyte Adhesion Deficiency Type II
Status:
Completed
Last Changed:
Jan 25, 2019
First Changed:
Nov 28, 2017
Disease(s):
Leukocyte Adhesion Deficiency, Type II
Intervention(s):
L-fucose
Second-line Therapy of Unresectable Cholangiocarcinoma by RADIOEMBOLIZATION
Status:
Terminated
Last Changed:
Aug 7, 2013
First Changed:
Jun 28, 2011
Disease(s):
Cholestasis, Progressive Familial Intrahepatic 3
Intervention(s):
Yttrium microsphere injection

Connect. Empower. Inspire.